|
Re: Win or lose....one thing we know for sure
|
5
|
Resverlogix Corp.
|
Aug 31, 2019 07:55AM
|
|
Will Apabetalone end up in China first?
|
5
|
Resverlogix Corp.
|
Aug 04, 2018 07:51AM
|
|
Article on Zenith....all financings in USD...expect Nasdaq IMHO
|
5
|
Zenith Epigenetics
|
May 18, 2016 07:57AM
|
|
Re: HDL Functionality
|
5
|
Resverlogix Corp.
|
May 09, 2019 03:13PM
|
|
Re: RVX-208 Moderated Poster Presentation at IAS 2015 May 26, 2015
|
5
|
Resverlogix Corp.
|
May 18, 2015 06:41PM
|
|
Re: Revamped website
|
5
|
Resverlogix Corp.
|
Jan 05, 2019 05:17PM
|
|
Re: What if
|
5
|
Resverlogix Corp.
|
Mar 06, 2019 01:05PM
|
|
Re: Great comments re safety Bear...
|
5
|
Resverlogix Corp.
|
Aug 30, 2018 09:43AM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
5
|
Resverlogix Corp.
|
Dec 05, 2019 07:24PM
|
|
Re: BRD4 regulates metastatic potential of castration-resistant prostate cancer through AHNAK
|
5
|
Zenith Epigenetics
|
May 21, 2019 05:37PM
|
|
Re: Short interest creeps up again.....
|
5
|
Resverlogix Corp.
|
Apr 20, 2017 05:13PM
|
|
Re: US Patent Application Publication filed Sept 16th by Resverlogix
|
5
|
Resverlogix Corp.
|
Sep 19, 2016 02:41PM
|
|
Re: Third Eye, AHA, US Listing
|
5
|
Resverlogix Corp.
|
Sep 11, 2019 04:18PM
|
|
Re: It seems ...
|
5
|
Resverlogix Corp.
|
Nov 09, 2015 10:48PM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
5
|
Resverlogix Corp.
|
Jan 30, 2019 03:49PM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
5
|
Resverlogix Corp.
|
Jan 30, 2019 04:15PM
|
|
Re: Options Exercised
|
5
|
Resverlogix Corp.
|
Jul 08, 2018 09:35AM
|
|
Re: Rodman and Renshaw Conf
|
5
|
Resverlogix Corp.
|
Sep 13, 2016 05:09PM
|
|
Good news
|
5
|
Resverlogix Corp.
|
Jul 25, 2017 09:14AM
|
|
NR out
|
5
|
Resverlogix Corp.
|
Jun 30, 2015 05:58PM
|
